Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds DYNDYNE THERAPEUTICS

15 funds on our shelf carry DYNE THERAPEUTICS — heaviest hand: IBRN at 3.27% of its book.

FundWeightFund assetsShares held
IBRNiShares Neuroscience and Healthcare ETFINDEX3.27%$6M16,499
SBIOALPS Medical Breakthroughs ETFACTIVE2.11%$114M228,641
WDNAWisdomTree BioRevolution FundACTIVE1.37%$3M3,661
XBIState Street SPDR S&P Biotech ETFINDEX0.76%$10.3B4,488,538
BBCVirtus Biotech Clinical Trials ETF0.73%—13,759
JDOCJPMorgan Healthcare Leaders ETFACTIVE0.51%$9M2,968
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.21%$112M15,657
IBBiShares Biotechnology ETFINDEX0.18%$10.6B1,170,307
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.15%$624M166,739
PWSPacer WealthShield ETFACTIVE0.15%$20M1,376
BIBProShares Ultra Nasdaq BiotechnologyINDEX0.13%$92M7,839
TCAFT. Rowe Price Capital Appreciation Equity ETFACTIVE0.11%$2.2B664,883
TMSLT. Rowe Price Small-Mid Cap ETFACTIVE0.10%$192M186,537
VHTVanguard Health Care Index FundINDEX0.03%$19B423,934
FHLCFidelity MSCI Health Care Index ETFINDEX0.03%$3.2B72,486

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.